CLEU DIAGNOSTICS LLC

Philadelphia, PA · Medtech · Private

Point-of-care diagnostic test using synovial fluid leukocyte esterase to detect periprosthetic joint infections

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
Philadelphia, PA
Total capital
$3.4M
Federal grants
$3.4M
5 awards · 2019–2023
Rank in peer group#36 of 79
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
9 pending · first 2021
Rank in peer group#12 of 79

Capital timeline

20192020202120222023FEDERAL ↑EQUITY ↓Cumulative $3.4M$225K$225K$1M$1.5M$471K
20192020202120222023FEDERAL ↑EQUITY ↓Cumulative $3.4M$225K$1M$1.5M$471K

Latest events

  • Federal grantHealth and Human S · Phase II · Rapid Electrochemical Biosensor For Point-of-care Diagnosis Of Joint Infection$471K
  • Federal grantHealth and Human S · Phase II · Rapid Electrochemical Biosensor For Point-of-care Diagnosis Of Joint Infection$1.5M
  • Federal grantHealth and Human S · Phase II · Rapid Electrochemical Biosensor For Point-of-care Diagnosis Of Joint Infection$1M
  • Federal grantHealth and Human S · Phase I · Rapid electrochemical biosensor for point-of-care diagnosis of joint infection$225K
  • Federal grantHealth and Human S · Phase I · Rapid electrochemical biosensor for point-of-care diagnosis of joint infection$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 79 peers

Line = median

Medtech · Instrument

  • Federal grants#36 · top 46%
  • Granted patents#12 · top 15%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 2 granted of 11
  • GrantedMultiplex Assay Reader And Microfluidic Test CartridgeUSPTOUS 12,629,678
  • PendingCompositions And Methods For Determining The Presence Of Active Leukocyte Cells Using An Electrochemical AssayUSPTOApplication 17342045
  • PendingCompositions And Methods For Determining The Presence Of Active Leukocyte Cells Using An Electrochemical AssayUSPTOApplication 17342077
Show all 11 patent records
  • Multiplex Assay Reader And Microfluidic Test CartridgeMay 19, 2026 · US 12,629,678Granted
  • Compositions And Methods For Determining The Presence Of Active Leukocyte Cells Using An Electrochemical AssayJan 20, 2022 · Application 17342045Pending
  • Compositions And Methods For Determining The Presence Of Active Leukocyte Cells Using An Electrochemical AssayDec 2, 2021 · Application 17342077Pending
  • Compositions And Methods For Determining The Presence Of Active Leukocyte Cells Using An Electrochemical AssayAug 31, 2021 · US 11,104,933Granted
  • Compositions And Methods For Determining The Presence Of Active Leukocyte Cells Using An Electrochemical AssayFeb 28, 2019 · Application 16087411Pending
  • Electrochemical Biosensor For Leukocyte EsteraseApplication 63523213Pending
  • Multicopper oxidases as single enzyme oxygen scavengers for electrochemical biosensorsApplication 63226411Pending
  • Highly compact self-aligning multiplex assay system with adhesive-free microfluidic test cardApplication 63527659Pending
  • Highly compact self-aligning multiplex assay system with adhesive-free microfluidic test cardApplication 63599854Pending
  • Electrochemical Biosensor For LeApplication PCTUS2024035630Pending
  • Multiplex Assay Reader And Microfluidic Test CartridgeApplication PCTUS2024038899Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .